Solid Biosciences Inc. (SLDB)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-96.8%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $8.09M | $13.62M | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$179.21M | -$129.73M | -$104.25M | -$106.45M | -$72.25M | -$88.41M | -$119.32M | -$75.69M | -$54.86M | -$25.58M |
| Net Income | -$174.32M | -$124.70M | -$96.02M | -$85.98M | -$72.19M | -$88.29M | -$117.22M | -$74.80M | -$53.18M | -$23.77M |
| EPS (Diluted) | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 | $-25.50 | — | — | — | — |
| Total Assets | $232.54M | $188.66M | $164.94M | $260.25M | $232.38M | $171.17M | $103.47M | $139.60M | $76.19M | — |
| Total Liabilities | $52.53M | $51.42M | $38.46M | $48.59M | $24.17M | $39.08M | $23.42M | $14.41M | $11.27M | — |
| Shareholders' Equity | $180.01M | $137.25M | $126.48M | $211.67M | $208.21M | $132.09M | $80.05M | $125.18M | — | — |
| Cash & Equivalents | $59.90M | $80.23M | $74.02M | $155.38M | $119.14M | $154.74M | $76.04M | $86.37M | $52.08M | $7.68M |
| Operating Cash Flow | -$156.29M | -$100.01M | -$94.18M | -$97.98M | -$77.76M | -$56.60M | -$92.71M | -$70.20M | -$43.22M | -$20.12M |
| Capital Expenditures | $1.15M | $654.0K | $1.51M | $3.02M | $1.28M | $899.0K | $4.39M | $7.78M | $2.28M | $392.0K |
| Shares Outstanding | 78.97M | 40.47M | 20.39M | 19.56M | 7.36M | 84.89M | 45.99M | 35.43M | 0 | — |